Literature DB >> 9213259

Prolonged intrahepatic cholestasis in acute-onset, severe autoimmune hepatitis.

Y Motoo1, N Sawabu, H Watanabe, T Okai, Y Nakanuma.   

Abstract

A 72-year-old woman was admitted because of jaundice and hepatocellular dysfunction. She was diagnosed with autoimmune hepatitis from laboratory test results showing high titers of antinuclear antibodies and negativity for hepatitis viral markers. Steroid i.v. pulse therapy and oral administration of prednisolone were effective in improving the liver function test results, except for hyperbilirubinemia. Elevated serum bilirubin levels, of approximately 20 mg/dl persisted for more than 6 months, despite the administration of ursodeoxycholic acid. Insulin-glucagon therapy was given for normalization of transaminases and then withdrawn 3 weeks after admission, but it was resumed at 3 months, resulting in a dramatic decrease in serum bilirubin levels, which then normalized in 2.5 months. Liver biopsy 6 months after onset showed chronic active hepatitis with bile plugs. Insulin-glucagon therapy, because of its choleretic effect, may be worth continuing even after recovery of acute hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213259     DOI: 10.1007/bf02934502

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  16 in total

1.  Effect of insulin and glucagon on fulminant murine hepatitis.

Authors:  M Farivar; J R Wands; K J Isselbacher; N L Bucher
Journal:  N Engl J Med       Date:  1976-12-30       Impact factor: 91.245

2.  Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

Authors:  S Vento; T Garofano; G Di Perri; L Dolci; E Concia; D Bassetti
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

3.  Meeting report: International Autoimmune Hepatitis Group.

Authors:  P J Johnson; I G McFarlane
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

4.  [A case of autoimmune hepatitis recovered from a fulminant like severe hepatic failure].

Authors:  K Ohnishi; Y Torimoto; M Ohhira; A Yasuda; A Matsumoto; Y Murazumi; M Mizuno; K Murazumi; H Ohta; H Kohda
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1994-09

5.  Effect of glucagon on secretin-stimulated bile flow.

Authors:  D L Kaminski; M J Ruwart; M Jellinek
Journal:  Am J Physiol       Date:  1975-12

6.  Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure.

Authors:  G Porta; L C Gayotto; F Alvarez
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-07       Impact factor: 2.839

7.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

8.  Autoimmune chronic active hepatitis in postmenopausal women.

Authors:  E Lebovics; F Schaffner; F M Klion; C Simon
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

9.  Acute liver biopsy lesions in early autoimmune ("lupoid") chronic active hepatitis.

Authors:  J H Lefkowitch; T F Apfelbaum; L Weinberg; G Forester
Journal:  Liver       Date:  1984-12

10.  Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

Authors:  L A Colombato; F Alvarez; J Côté; P M Huet
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

View more
  1 in total

1.  Diagnostic approach to patients with cholestatic jaundice.

Authors:  N Assy; G Jacob; G Spira; Y Edoute
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.